Concepedia

Author

Paul Mésange

Hôpital Saint-Antoine

Also Known As

Mésange, Paul, P. Mesange, P. Mésange, Paul Mesange, Paul Mésange

28

Publications

418

Citations

6

H-Index

10

Concepts

All Affiliations

Hôpital Saint-AntoineSorbonne UniversitéMethodology and Quality of Life Unit in OncologyInstitut Paoli-CalmettesInstitut Hospitalier Franco Britannique
PM

About

Paul Mésange is an author at Hôpital Saint-Antoine specializing in radiation oncology, cancer therapeutics, and colorectal cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

130

2

Cancer Therapeutics

2

2

130

3

Health Sciences

1

1

120

4

Pathology

1

1

10

5

Clinical Trials

1

1

120

Paul Mésange

×

5

Publications

363

Citations

5

H-Index

YearCitations

Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension

Rasa Tamošiūnienė, Olga Manouvakhova, Paul Mésange,

Circulation Research

2018

137

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial

Christophe Tournigand, Benoist Chibaudel, Benoît Samson,

The Lancet Oncology

2015

120

Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor

Paul Mésange, Virginie Poindessous, Michèle Sabbah,

Oncotarget

2014

71

Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of <i>RAS</i> Status

Paul Mésange, Anaïs Bouygues, Nathalie Ferrand,

Clinical Cancer Research

2018

25

Bevacizumab-Erlotinib As Maintenance Therapy in Metastatic Colorectal Cancer. Final Results of the Gercor Dream Study

Benoist Chibaudel, Christophe Tournigand, Benoît Samson,

Annals of Oncology

2014

10

Page 1